IQMDU (Intelligent Medicine Acquisition) Quality Rank

View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:

Interest coverage
Zscore
Debt to revenue
Equity to asset
Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:

Operating margin mean rank (10-year mean average profit margine)
Operating margin growth rank
Fscore
Predictability rank
Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
Num of year profit (number of years that is profitable within the last 10 years)
ROIC median (10-year median of ROIC)

Intelligent Medicine Acquisition Quality Rank Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelligent Medicine Acquisition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Quality Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

9001 Burdette Road, Bethesda, MD, USA, 20817

Website

https://iqmdspac.com

Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

Executives

Goldman Sachs & Co. Llc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken	director	2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary	director	3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon	director, officer: CEO and CFO	9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball	director	9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc	10 percent owner	9001 BURDETTE ROAD, BETHESDA MD 20817